Benchmark's initiation adds a fresh bullish voice to a stock already heavily favored by analysts, but the real edge lies in the insider buying and extreme short interest. Traders should watch for a squeeze if the stock breaks above resistance; the near-term EPS weakness makes this a tactical rather than core long position.
Price Chart
Executive Summary
Benchmark initiated coverage on IFF at Buy with a $100 price target, implying 36% upside from the current $73.56 close. The firm is one of the most active covering the stock, with a 54% accuracy rate on 1,703 calls and an average return of 6%. Consensus on IFF is overwhelmingly bullish: 15 of 21 analysts rate it Buy (71.4%), 6 Hold, and none Sell. The mean price target is $91.16, with a range of $71 to $105, placing Benchmark's $100 target well above the mean. Momentum is lopsided — only one analyst action in the past 30 days (this initiation) and zero downgrades — but near-term EPS revisions have turned negative (9 downgrades vs 1 upgrade for the current quarter), creating a divergence. Insider buying adds a confirming bullish signal, with executives Fribourg and Fyrwald purchasing over $2M in March and June. However, the short interest ratio of 75.1% reflects heavy bearish positioning, making the analyst call a potential contrarian bet against crowded shorts. The high short interest combined with insider accumulation creates a tactical squeeze opportunity for traders willing to look past near-term earnings caution.
Impact Score
Consensus & Targets
The consensus among 21 analysts covering IFF is strongly bullish: 5 Strong Buy, 10 Buy, and 6 Hold, with zero Sell/Strong Sell ratings. That translates to 71.4% Buy-equivalent ratings and 28.6% Hold, reflecting broad optimism despite recent share weakness.
The mean price target is $91.16, median $92, with a high of $105 and a low of $71. At $73.56, the stock trades at a 19.3% discount to the mean target. Benchmark's $100 target ranks near the top of the range, above both the mean and median, and is just 4.8% below the street-high of $105.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-09 | Benchmark | initiate | Buy | $100.00 |
| 2026-05-08 | Barclays | maintain | Overweight | $90.00 |
| 2026-05-07 | Citigroup | maintain | Buy | $96.00 |
| 2026-05-07 | JP Morgan | maintain | Overweight | $92.00 |
| 2026-05-07 | Oppenheimer | maintain | Outperform | $90.00 |
| 2026-04-22 | Oppenheimer | maintain | Outperform | $88.00 |
| 2026-04-14 | Barclays | maintain | Overweight | $80.00 |
| 2026-04-13 | Citigroup | maintain | Buy | $90.00 |
| 2026-04-09 | UBS | maintain | Neutral | $75.00 |
| 2026-02-17 | Barclays | maintain | Overweight | $91.00 |
In the past 30 days, there has been 1 upgrade (this initiation) and 0 downgrades. EPS revision trends are mixed: long-term estimates have risen (10 up, 3 down for the current fiscal year; 12 up, 3 down for next year), but near-term quarterly estimates are under pressure — the current quarter has 9 downward revisions vs 1 upward, and the next quarter has 6 down vs 4 up. This suggests analysts are hedging on short-term execution while looking past it for the year.
Firm Track Record — Benchmark
Benchmark accuracy: 54% on 1703 calls | avg return: 6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Mizuho | 75% | 3/4 | 0% | top tier |
| Stifel | 60% | 3/5 | -1.9% | above average |
| Citigroup | 57% | 4/7 | 3.5% | above average |
| Morgan Stanley | 57% | 4/7 | 2.9% | above average |
| Argus Research | 50% | 1/2 | -1.5% | below average |
| Tigress Financial | 50% | 1/2 | -4.8% | below average |
| Oppenheimer | 40% | 2/5 | -3.9% | below average |
| UBS | 38% | 3/8 | 0.5% | below average |
| B of A Securities | 33% | 1/3 | 3.9% | below average |
| Wells Fargo | 33% | 2/6 | 1.6% | below average |
Benchmark has a 54% accuracy rate on 1,703 rated stocks, with an average return of 6%. Among firms covering IFF, the best performers by accuracy are Mizuho (75% on 4 calls) and Stifel (60% on 5 calls), while the worst are JP Morgan (0% on 5) and Baird (0% on 2). Benchmark's accuracy places it in the middle-to-upper tier, ahead of UBS (38%), BofA (33%), and Barclays (22%).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0y | $4.49 | $4.25 — $4.77 | $10.6B | ↑0 ↓0 |
| +1y | $4.78 | $4.27 — $5.25 | $10.6B | ↑1 ↓0 |
| +1q | $1.14 | $1.07 — $1.23 | $2.7B | ↑0 ↓0 |
| 0q | $1.12 | $1.05 — $1.14 | $2.7B | ↑0 ↓0 |
Cross-Platform Signals
Insider trades align strongly with the bullish call: CEO Fyrwald bought $933k in March and $62k in March, and director Fribourg bought $995k in March and $1M on June 1 — a clear cluster of insider accumulation. Institutional flows show a mixed picture: Renaissance Technologies nearly exited (-96.6%), while Norges Bank both entered and exited. Short interest is extreme — 75.1% short ratio — implying heavy bearish bets. The convergence of insider buying and analyst initiation against extreme short interest creates a potential squeeze setup, but the institutional exits add caution.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | ANALYST-UPGRADE | $83.61 $82.96 | ▼ −0.78% | ▼ −0.56% | $83.13 (−0.57%) |
Aug 10, 2026 7w ago | Insider Cluster | $85.00 $81.00 | ▼ −4.71% | ▼ −4.30% | $83.13 (−2.20%) |
Jul 20, 2026 10w ago | Press Release | $76.26 $76.40 | ▲ +0.18% | ▲ +1.41% | $83.13 (+9.01%) |
Jun 23, 2026 14w ago | 8-K | $75.83 $81.15 | ▲ +7.02% | ▲ +5.31% | $83.13 (+9.63%) |
Jun 9, 2026 16w ago | ANALYST-UPGRADE | $75.78 $78.36 | ▲ +3.40% | ▲ +0.99% | $83.13 (+9.70%) |
Jun 1, 2026 17w ago | 8-K | $74.26 $73.01 | ▼ −1.68% | ▲ +1.07% | $83.13 (+11.94%) |
Mar 18, 2026 28w ago | DEFA14A | $67.91 $70.71 | ▲ +4.12% | ▲ +4.84% | $83.13 (+22.41%) |
Mar 12, 2026 29w ago | Insider Cluster | $69.60 $67.73 | ▼ −2.69% | ▼ −1.71% | $83.13 (+19.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access